Elon Musk’s Neuralink appears to be what I’ve always suspected it would be: a slapdash company where progress seems to take a higher priority than saftey. As a neurologist who has clinical trial expertise and experience with neuromodulation devices, I don’t see this company getting FDA approval anytime soon.

reuters.com/investigates/speci

@OldHound what do you think of the mission though? Higher spatial resolution than EEG, higher temporal resolution than fMRI, and on free-moving animals is, I think, their goal. For neuroscience as a field, I've understood the central problems to require a model of a system of systems to integrate the massive amounts of data we already have. I'm not sure how much Neuralink helps there, though being able to get the devices on free-moving animals seems useful.

For technology, Neuralink could be useful in some prosthetics for paralyzed folks, right?

@2ck Why would you think that any other companies aren’t working on this “mission”? If anything, Musk is a late entrant on all of this and I’d take a lot of his claims with a grain of salt (he tends to overhype). His tendency to flagrantly ignore regulations, particularly in the area of human research, is extremely concerning. There’s a history as to why those regulations are in place (and I should add, the bar is lower for device manufacturers).

Follow

@OldHound Thanks for your response. I don't think other companies aren't developing similar devices. I've read about a few over the years. I'm looking forward to seeing more from Synchron, for instance since they got approved for clinical trials.

I think that higher electrode density may or may not be major factor in how effective future devices are. I was hoping you could share your thoughts since you have industry experience.

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.